Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 119 (RPL21P119)

Target
RPL21P119
Molecular classification
Other (Pseudogene), Not an enzyme, receptor, transporter, channel, or ion channel
01

Overview

RPL21P119, or "ribosomal protein L21 pseudogene 119," is a processed pseudogene related to the ribosomal protein L21 family. It is one of many non-functional genomic copies (processed pseudogenes) of the RPL21 gene distributed throughout the genome. Unlike the protein-coding parent RPL21 gene, which encodes a component of the 60S ribosomal subunit, RPL21P119 does not encode a functional protein and is not expressed as a functional product. Pseudogenes generally lack known biological function and are not relevant as therapeutic targets or disease biomarkers. The parent gene RPL21 is involved in protein synthesis as part of the ribosomal machinery, but the pseudogene RPL21P119 has no such role.

Other names
RPL21_56_1471RPL21P119
02

Mechanism of action

None

03

Biological functions

None (RPL21P119 does not appear to encode a functional molecule)Pseudogenes in general may contribute to gene regulation (for example, as non-coding RNAs), but there is no evidence for such a function here
04

Disease associations

None knownMutations in the parent gene *RPL21* (not the pseudogene) are associated with rare diseases such as Hypotrichosis simplex of the scalp, but RPL21P119 itself is not implicated

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 119 (RPL21P119).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 119 (RPL21P119).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call